
AI is about to change healthcare. These 34 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own Silgan, you need to be comfortable with a steady, cash generative packaging business where capital returns are central to the story. The 5% dividend hike supports that view and may help sentiment after a weaker 1 year total return, but it does not change the near term focus on managing softer sales trends and the key risk around cost pressures and shifting customer demand.
This latest dividend increase sits alongside an active capital allocation program, including the US$500 million share repurchase authorization running through 2029. Together, these moves frame Silgan as a company prioritizing consistent cash returns, which can be a supporting factor if volume growth is modest and supply chain competition remains intense.
Yet, while the dividend looks reassuring, investors should also be aware of...
Read the full narrative on Silgan Holdings (it's free!)
Silgan Holdings' narrative projects $7.0 billion revenue and $392.2 million earnings by 2029. This requires 2.4% yearly revenue growth and about a $103.8 million earnings increase from $288.4 million.
Uncover how Silgan Holdings' forecasts yield a $55.27 fair value, a 34% upside to its current price.
Some of the lowest ranked analysts were already cautious, assuming only about 3.8 percent annual revenue growth and US$451.7 million of earnings by 2028, so this dividend news could either challenge or reinforce their more pessimistic view depending on how you weigh it against rising interest costs and acquisition related risks.
Explore 3 other fair value estimates on Silgan Holdings - why the stock might be worth as much as 94% more than the current price!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Every day counts. These free picks are already gaining attention. See them before the crowd does:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com